Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Endocrine 1Breast 1

Conditions

Breast Neoplasms 13132Triple Negative Breast Neoplasms 1149Neoplasms 749Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 580Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 535Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 203Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Insipidus × Breast × Clear all
NCT00390962 2008-09-23

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

University Hospital, Basel, Switzerland

Completed
469 enrolled
Breast

Hemorrhagic Stroke, Carcinoma, Intraductal, Noninfiltrating, Ischemic Attack, Transient, Diabetes Insipidus, Inappropriate ADH Syndrome, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡